Liquid-Biopsy Glycan Score Biomarker Accurately Indicates and Stratifies Primary and Metastatic Prostate Cancers
Analytical Chemistry · 2024
DOI: 10.1021/acs.analchem.4c04316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2024. Verfasst von Ana Díaz-Fernández und 7 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Nanoscience Center (iNANO), Faculty of Natural Sciences, Aarhus University, Gustav Wieds Vej 14, 8000 Aarhus C, Denmark. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Biomarkers, Tumor, Polysaccharides, Prostate-Specific Antigen. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Novo Nordisk, Kr?ftens Bek?mpelse, L?ge Sofus Carl Emil Friis og Hustru Olga Doris Friis' Legat.
Abstract (Originalsprache)
Prostate cancer (PCa) is the most commonly diagnosed cancer in males. Early PCa usually shows no clinical symptoms and its primary diagnosis is currently guided by liquid-biopsy testing of serum prostate-specific antigen (PSA). This testing suffers from high false-positive and false-negative rates. Identifying new biomarkers for precise liquid-biopsy detection of PCa is, thus, an acute clinical request. Here, by using an advanced dual-functional aptamer assay, we quantified the extent of glycosylation of PSA circulating in cancer patients' serum, linked it to cancer-related breakage of PSA complexes with serum-circulating proteins, and proved its facility for stratification of primary and metastatic PCa. PSA's "Glycan Score" 100% accurately informed about PCa status in a 30-patient cohort, while serum PSA's concentration correctly classified only 53% of PCa patients and did not inform about their PCa status. The Glycan Score liquid-biopsy test thus has a huge potential for accurate diagnosis and staging of PCa, enabling mass-screening program progress and advanced PCa treatment monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Interdisciplinary Nanoscience Center (iNANO), Faculty of Natural Sciences, Aarhus University, Gustav Wieds Vej 14, 8000 Aarhus C, Denmark.
- Department of Nuclear Medicine & PET Centre, Aarhus University Hospital, Palle Juul-Jensens Boulevard 165, 8200 Aarhus N, Denmark.
- Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark.
- Department of Molecular Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark.
- Department of Urology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark.
- Department of Biomedicine, Aarhus University, Høegh-Guldbergs Gade 10, 8000 Aarhus C, Denmark.
ORCID-Profile: Elena E Ferapontova
Förderung
- Novo Nordisk
- Kr?ftens Bek?mpelse
- L?ge Sofus Carl Emil Friis og Hustru Olga Doris Friis' Legat
- Fabrikant Einar Willumsens Mindelegat
- Aage og Johanne Louis-Hansens Fond
Zitieren
APA
Díaz-Fernández, A., Ryø Jochumsen, M., Christensen, N. L., Dalsgaard Sørensen, K., Bouchelouche, K., Borre, M., Holm Vendelbo, M., & Ferapontova, E. E. (2024). Liquid-Biopsy Glycan Score Biomarker Accurately Indicates and Stratifies Primary and Metastatic Prostate Cancers. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.4c04316
Vancouver
Díaz-Fernández A, Ryø Jochumsen M, Christensen NL, Dalsgaard Sørensen K, Bouchelouche K, Borre M, et al. Liquid-Biopsy Glycan Score Biomarker Accurately Indicates and Stratifies Primary and Metastatic Prostate Cancers. Analytical Chemistry. 2024. doi:10.1021/acs.analchem.4c04316
BibTeX
@article{DazFernndez2024,
author = {Díaz-Fernández, Ana and Ryø Jochumsen, Mads and Christensen, Nana Louise and Dalsgaard Sørensen, Karina and Bouchelouche, Kirsten and Borre, Michael and Holm Vendelbo, Mikkel and Ferapontova, Elena E},
title = {Liquid-Biopsy Glycan Score Biomarker Accurately Indicates and Stratifies Primary and Metastatic Prostate Cancers},
journal = {Analytical Chemistry},
year = {2024},
doi = {10.1021/acs.analchem.4c04316}
}
EUVIMED